MUQUABIS (101070546)

  https://cordis.europa.eu/project/id/101070546

  Horizon Europe (2021-2027)

  Multiscale quantum bio-imaging and spectroscopy

  Next generation quantum sensing technologies (RIA) (HORIZON-CL4-2021-DIGITAL-EMERGING-01-21)

  cardiac arrhythmia  ·  sensors  ·  quantum optics  ·  biophysics  ·  spectroscopy

  2022-07-01 Start Date (YY-MM-DD)

  2026-06-30 End Date (YY-MM-DD)

  € 6,664,541


  Description

Understanding and controlling complex systems at different scales is a major challenge in biology and medicine. Quantum sensing technologies hold much promise for disruptive approaches to imaging and spectroscopy of biological matter. MUQUABIS aims at developing synergetic tools of quantum bio-sensing and bio-imaging. Such sensors will offer biology a distinctive host of powerful features – non-invasiveness, sensitivity, spatial and temporal resolutions, likely to conquer new frontiers in imaging and spectroscopy, out-of-reach of their classical counterparts. A focus is a global structural and functional understanding of cardiac cell layers from molecules to cells to tissues. ¬Their study in healthy and diseased conditions will shed light on cardiac arrhythmias, largely responsible for morbidity and sudden cardiac death. Advancing beyond modern tools of photonics and quantum measurements, new concepts for quantum frequency combs and infrared lasers will be explored. Low-light-level spectro-imaging will detect cell-membrane proteins and gaseous metabolites nearby cell tissues, below the quantum noise limit. Concurrently, a quantum magneto-microscope based on diamond nitrogen-vacancy centers will be combined to optical imaging for electrophysiology. Such a hybrid sensor will simultaneously and locally reveal the magnetic and electric fields in cardiac-cell activity. MUQUABIS proposes a unique synergic effort, gathering complementary expertise, technologies and infrastructures. Leading research institutions in quantum sensing, quantum optics and biophysics, together with four high-tech companies will rapidly move the project from fundamental quantum sensing components and protocols to technology validation on biological samples to a roadmap for industrial exploitation. MUQUABIS will pave the way to ground-breaking quantum-based tools and protocols for medical diagnostics and treatments, a strategic objective for the European Quantum Technology flagship.


  Complicit Organisations

1 Israeli organisation participates in MUQUABIS.

Country Organisation (ID) VAT Number Role Activity Type Total Cost EC Contribution Net EC Contribution
Czechia FAKULTNI NEMOCNICE U SV ANNY V BRNE (994491822) CZ00159816 participant HES € 498,860 € 498,860 € 498,860
Germany JOHANNES GUTENBERG-UNIVERSITAT MAINZ (999978627) DE149065685 participant HES € 800,105 € 800,105 € 800,105
Italy UNIVERSITA CAMPUS BIO MEDICO DI ROMA (999440665) IT04802051005 participant HES € 519,706 € 519,706 € 519,706
Germany QLIBRI GMBH (888946995) DE351721541 participant PRC € 399,962 € 399,962 € 399,962
Italy CONSIGLIO NAZIONALE DELLE RICERCHE (999979500) IT02118311006 coordinator REC € 1,899,290 € 1,899,290 € 1,899,290
Italy LEONARDO - SOCIETA PER AZIONI (998627417) IT00881841001 participant PRC € 496,250 € 496,250 € 496,250
Israel THE HEBREW UNIVERSITY OF JERUSALEM (999975038) IL500701610 participant HES € 800,000 € 800,000 € 800,000
United Kingdom ELEMENT SIX (UK) LIMITED (924659485) GB238990322 associatedPartner PRC € 0 € 0 € 0
Germany MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV (999990267) DE129517720 participant REC € 850,367 € 850,367 € 850,367
Italy PPQSENSE SRL (907860540) IT06644470483 participant PRC € 400,000 € 400,000 € 400,000